Warning letter

Walgreens Infusion Services: warning letter of Oct 19, 2016

FDA warning letter UCM526853 · Dallas District Office

Key facts

Reference number UCM526853
Company Walgreens Infusion Services
Subject Drug Product/Adulterated
Issue date Oct 19, 2016
Posted date Oct 19, 2016
Issuing office Dallas District Office
Product type Drugs
Country 3
Letter on fda.gov web.archive.org

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters